Evidence map›Paper›PMID 33847980›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Genome Editing in Y. lipolytica Using TALENs.

Coraline Rigouin, Christian Croux, Gwendoline Dubois, Fayza Daboussi, Florence Bordes

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. A review of synthetic biology tools in Yarrowia lipolytica.World journal of microbiology & biotechnology · 2023
    Review
  4. Journal of fungi (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Coraline RigouinLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Christian CrouxLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Gwendoline DuboisLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Fayza DaboussiLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Florence BordesLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France. bordes@insa-toulouse.fr.
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRInstitut National des Sciences Appliquées de Toulouse · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TALENs (Transcription Activator-Like EndoNuclease) are molecular scissors designed to recognize and introduce a double-strand break at a specific genome locus. They represent tools of interest in the frame of genome edition. Upon cleavage, two different pathways lead to DNA repair: Non-homologous End Joining (NHEJ) repair, leading to efficient introduction of short insertion/deletion mutations which can disrupt translational reading frame and Homology Recombination (HR)-directed repair that occurs when exogenous DNA is supplied. Here we introduce how to use TALENs in the oleaginous yeast Yarrowia lipolytica by presenting a step-by-step method allowing to knock out or to introduce in vivo a point mutation in a gene of Yarrowia lipolytica. This chapter describes the material required, the transformation procedure, and the screening process.

Indexed as

DNA End-Joining RepairGene EditingGenome, FungalPoint MutationSoftwareTranscription Activator-Like Effector NucleasesYarrowiaTranscription Activator-Like Effector NucleasesGenome editingIn vivo directed mutagenesisTALENYarrowia lipolytica

Identifiers

PMID33847980
OpenAlexW3156825261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.